Edema of the face and extremities secondary to pemetrexed

• Thomas Doyle, MS,
• Christopher J. Fay, BA,
• Catherine Pisano, MD,
• Nicole R. LeBoeuf, MD, MPH

Affiliations

Thomas Doyle, MS

Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

Christopher J. Fay, BA

Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts

Catherine Pisano, MD

Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts

Nicole R. LeBoeuf, MD, MPH

Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Correspondence to: Nicole R. LeBoeuf, MD, MPH, Center for Cutaneous Oncology, Dana-Farber Brigham Cancer Center, 450 Brookline Ave, Boston, MA 02115.